Product Categories
| Country: | China |
|---|---|
| Tel: | 021-59167510 |
| Mobile: | 18117107507 |
| E-mail: | vip@med-life.cn |
| QQ: | 252984528 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Thalidomide-Piperazine-PEG1-COOH | C22H26N4O7 | 2731007-11-5 | Details |
| Pomalidomide-PEG4-C-COOH | C23H29N3O10 | 2097938-44-6 | Details |
| MRT00033659 | C15H14N4O | 1401731-54-1 | Details |
| GSK682753A | C23H21Cl3N2O3 | 1334294-76-6 | Details |
| ML401 | C20H20BrClN2O | 1597489-14-9 | Details |
| NIBR189 | C21H21BrN2O3 | 1599432-08-2 | Details |
| EAI045 | C19H14FN3O3S | 1942114-09-1 | Details |
| EAI001 | C19H15N3O2S | 892772-75-7 | Details |
| ARRY-380 analog | C29H27N7O4S | 937265-83-3 | Details |
| TAS0728 | C26H32N8O3 | 2088323-16-2 | Details |
| Zipalertinib | C23H20N6O | 1661854-97-2 | Details |
| Alflutinib mesylate | C29H35F3N8O5S | 2130958-55-1 | Details |
| JND3229 | C33H41ClN8O2 | 2260886-64-2 | Details |
| Gefitinib-based PROTAC 3 | C47H57ClFN7O8S | 2230821-27-7 | Details |
| Nazartinib | C26H31ClN6O2 | 1508250-71-2 | Details |
| EGFR-IN-11 | C29H35N9O2S | 2463200-44-2 | Details |
| AZ7550 Mesylate | C28H35N7O5S | 2319837-99-3 | Details |
| CP-724714 | C27H27N5O3 | 537705-08-1 | Details |
| BMS-690514 | C19H24N6O2 | 859853-30-8 | Details |
| PD153035 hydrochloride | C16H14BrN3O2 | 153436-54-5 | Details |
| AG-1478 | C16H14ClN3O2 | 153436-53-4 | Details |
| AST-1306 | C24H18ClFN4O2 | 897383-62-9 | Details |
| Mutant EGFR inhibitor | C27H30ClN7O2 | 1421373-62-7 | Details |
| AZD-9291 (Mesylate) | C29H37N7O5S | 1421373-66-1 | Details |
| Thalidomide-piperazine-Boc | C22H26N4O6 | 2222114-64-7 | Details |
| Simotinib | C25H26ClFN4O4 | 944258-89-3 | Details |
| Lazertinib | C30H34N8O3 | 1903008-80-9 | Details |
| Thalidomide 4'-ether-alkylC2-amine hydrochloride | C15H16ClN3O5 | 2341840-99-9 | Details |
| Thalidomide-NH-PEG3-propionic acid | C22H27N3O9 | 2138440-82-9 | Details |
| HLM006474 | C25H25N3O2 | 353519-63-8 | Details |
| PD168393 | C17H13BrN4O | 194423-15-9 | Details |
| (S,R,S)-AHPC-phenol-C4-NH2 dihydrochloride | C28H42ClN5O5S | 2376990-26-8 | Details |
| Lapatinib ditosylate monohydrate | C41H40ClFN4O11S3 | 388082-78-8 | Details |
| (E/Z)-AG490 | C17H14N2O3 | 134036-52-5 | Details |
| Almonertinib mesylate | C31H39N7O5S | 2134096-06-1 | Details |
| Antiviral agent 24 | C18H18F3N5O4 | 23661-03-2 | Details |
| 123C4 | C43H47ClN8O6 | 2034159-30-1 | Details |
| MB05032 | C11H15N2O4PS | 261365-11-1 | Details |
| Linagliptin | C25H28N8O2 | 668270-12-0 | Details |
| FIN56 | C25H31N3O5S2 | 1083162-61-1 | Details |
| iFSP1 | C20H13N5 | 150651-39-1 | Details |
| GPX4-IN-3 | C29H24ClN3O3S | 2761004-85-5 | Details |
| Pifithrin-β hydrobromide | C16H16N2S.HBr | 511296-88-1 | Details |
| NADPH tetrasodium salt | C21H31N7NaO17P3 | 2646-71-1 | Details |
| Eugenol-d3 | C10H12O2 | 1335401-17-6 | Details |
| Alogliptin-d3 | C18H21N5O2 | 1133421-35-8 | Details |
| Setanaxib | C21H19ClN4O2 | 1218942-37-0 | Details |
| OSI-420 free base | C21H21N3O4 | 183321-86-0 | Details |
| AZD3759 | C22H23ClFN5O3 | 1626387-80-1 | Details |
| RG 13022 | C16H14N2O2 | 136831-48-6 | Details |
| Compound 56 | C18H18BrN3O2 | 171745-13-4 | Details |
| Pleconaril | C18H18F3N3O3 | 153168-05-9 | Details |
| Erastin2 | C36H35ClN4O4 | 1695533-44-8 | Details |
| AR-9281 | C18H29N3O2 | 913548-29-5 | Details |
| AP-III-a4 | C31H43FN8O3 | 1177827-73-4 | Details |
| Golgicide A-2 | C17H14F2N2 | 1394285-50-7 | Details |
| Rupintrivir | C31H39FN4O7 | 223537-30-2 | Details |
| Pirodavir | C21H27N3O3 | 124436-59-5 | Details |
| UAMC-3203 hydrochloride | C25H38ClN5O2S | 2271358-65-5 | Details |
| Pioglitazone-d4 | C19H16D4N2O3S | 1134163-29-3 | Details |
| Deferasirox | C21H15N3O4 | 201530-41-8 | Details |
| ONO-AE3-208 | C24H21FN2O3 | 402473-54-5 | Details |
| Pioglitazone | C19H20N2O3S | 111025-46-8 | Details |
| Dopamine-d5 (hydrochloride) | C8H6D5NO2.ClH | 2193106-55-5 | Details |
| Ifebemtinib | C28H28F4N6O4 | 1227948-82-4 | Details |
| BI-4464 | C28H28F3N5O4 | 1227948-02-8 | Details |
| GSK215 | C50H59F3N10O6S | 2743427-26-9 | Details |
| PND-1186 | C25H26F3N5O3 | 1061353-68-1 | Details |
| sEH inhibitor-7 | C15H21NO2 | 340221-20-7 | Details |
| GSK2256294A | C21H24F3N7O | 1142090-23-0 | Details |
| JWG-071 | C34H44N8O3 | 2250323-50-1 | Details |
| BAY885 | C25H28F3N7O2 | 2307249-33-6 | Details |
| FAPI-46 | C41H57F2N11O9 | 2374782-04-2 | Details |
| FAPI-34 | C50H57F2N13O18 | 2374782-07-5 | Details |
| FAP-2286 | C67H99N13O18S3 | 2581741-18-4 | Details |
| KO-947 | C21H17N5O | 1695533-89-1 | Details |
| FR 180204 | C18H13N7 | 865362-74-9 | Details |
| ASTX029 | C29H31ClFN5O5 | 2095719-92-7 | Details |
| Anti-inflammatory agent 35 | C27H29NO8 | 2293951-00-3 | Details |
| RLX-33 | C24H19ClN4O4 | 2784577-71-3 | Details |
| Ravoxertinib | C21H18ClFN6O2 | 1453848-26-4 | Details |
| Ulixertinib (hydrochloride) | C21H23Cl3N4O2 | 1956366-10-1 | Details |
| DY131 | C18H21N3O2 | 95167-41-2 | Details |
| URB597 | C20H22N2O3 | 546141-08-6 | Details |
| BMS-962212 | C32H28ClFN8O5 | 1430114-34-3 | Details |
| Edoxaban tosylate | C24H30ClN7O4S.C7H8O3S | 480449-71-6 | Details |
| Ozagrel | C13H12N2O2 | 82571-53-7 | Details |
| ERK1/2 inhibitor 1 | C29H32ClN5O4 | 2095719-90-5 | Details |
| Darexaban | C27H30N4O4 | 365462-23-3 | Details |
| (rel)-AR234960 | C27H30FN5O5S | 1408311-94-3 | Details |
| Lidocaine | C14H22N2O | 137-58-6 | Details |
| BI-3663 | C44H42F3N7O12 | 2341740-84-7 | Details |
| Defactinib | C20H21F3N8O3S | 1073154-85-4 | Details |
| BIX02188 | C25H24N4O2 | 334949-59-6 | Details |
| XMD17-109 | C36H46N8O3 | 1435488-37-1 | Details |
| Asundexian | C26H21ClF4N6O4 | 2064121-65-7 | Details |
| GSK2256098 | C20H23ClN6O2 | 1224887-10-8 | Details |
| Conteltinib | C32H45N9O3S | 1384860-29-0 | Details |
| Tizaterkib | C24H24F2N8O2 | 2097416-76-5 | Details |
| LM22B-10 | C27H33ClN2O4 | 342777-54-2 | Details |
| Product Total： Product Page： | ||||
| 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 | ||||